Hunan Hansen Pharmaceutical Co Ltd (002412) — Financial Flexibility Index
Hunan Hansen Pharmaceutical Co Ltd (002412) has a Financial Flexibility Index of 0.19x as of September 2025. Free cash flow of CN¥56.32 Million (operating CF CN¥52.51 Million minus capex CN¥3.82 Million) represents 0% of total liabilities (CN¥301.66 Million). Also explore 002412 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hunan Hansen Pharmaceutical Co Ltd Financial Flexibility Index (2007–2024)
Historical Financial Flexibility Index trend for Hunan Hansen Pharmaceutical Co Ltd across 18 annual periods. Check Hunan Hansen Pharmaceutical Co Ltd (002412) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Hunan Hansen Pharmaceutical Co Ltd (2007–2024)
Year-by-year free cash flow to debt coverage for Hunan Hansen Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Hunan Hansen Pharmaceutical Co Ltd stock valuation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.41x | CN¥142.42 Million | CN¥130.78 Million | CN¥343.85 Million | ▼ -14.3% |
| 2023 | 0.48x | CN¥180.42 Million | CN¥160.95 Million | CN¥373.46 Million | ▲ +23.4% |
| 2022 | 0.39x | CN¥155.31 Million | CN¥143.81 Million | CN¥396.81 Million | ▼ -67.3% |
| 2021 | 1.20x | CN¥441.87 Million | CN¥212.54 Million | CN¥368.99 Million | ▲ +20.8% |
| 2020 | 0.99x | CN¥291.27 Million | CN¥162.19 Million | CN¥293.92 Million | ▲ +74.2% |
| 2019 | 0.57x | CN¥200.82 Million | CN¥165.11 Million | CN¥352.93 Million | ▼ -12.2% |
| 2018 | 0.65x | CN¥282.05 Million | CN¥217.52 Million | CN¥435.02 Million | ▲ +98.2% |
| 2017 | 0.33x | CN¥157.38 Million | CN¥107.18 Million | CN¥481.18 Million | ▼ -34.0% |
| 2016 | 0.50x | CN¥206.07 Million | CN¥161.16 Million | CN¥415.88 Million | ▼ -54.9% |
| 2015 | 1.10x | CN¥139.46 Million | CN¥63.57 Million | CN¥126.83 Million | ▲ +48.6% |
| 2014 | 0.74x | CN¥158.80 Million | CN¥85.05 Million | CN¥214.59 Million | ▼ -14.0% |
| 2013 | 0.86x | CN¥184.53 Million | CN¥76.09 Million | CN¥214.46 Million | ▼ -70.0% |
| 2012 | 2.87x | CN¥220.10 Million | CN¥100.23 Million | CN¥76.76 Million | ▲ +71.7% |
| 2011 | 1.67x | CN¥91.74 Million | CN¥53.84 Million | CN¥54.95 Million | ▲ +231.3% |
| 2010 | 0.50x | CN¥24.81 Million | CN¥21.24 Million | CN¥49.23 Million | ▼ -44.6% |
| 2009 | 0.91x | CN¥61.56 Million | CN¥41.02 Million | CN¥67.69 Million | ▲ +63.9% |
| 2008 | 0.55x | CN¥46.98 Million | CN¥33.94 Million | CN¥84.67 Million | ▼ -12.6% |
| 2007 | 0.64x | CN¥54.93 Million | CN¥37.75 Million | CN¥86.49 Million | — |